# Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

> **NCT01481493** · PHASE2 · COMPLETED · sponsor: **Biotest** · enrollment: 127 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** BT061
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01481493
- **Lead sponsor:** Biotest
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2013-08
- **Final completion:** 2013-11
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2015-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481493, "Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01481493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*